A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

Clinical trial NCT05367700 · RECRUITING

Trial details

NCT number: NCT05367700
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CML, Chronic Phase CML, Accelerated Phase

Start date: 2022-04-28
Primary completion: 2024-12-30
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.